SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2016

  • ID: 3693089
  • Company Profile
  • 49 pages
  • Global Markets Direct
1 of 4
SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2016

Summary

‘SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2016’, provides an overview of the SK Biopharmaceuticals Co., Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by SK Biopharmaceuticals Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of SK Biopharmaceuticals Co., Ltd.
- The report provides overview of SK Biopharmaceuticals Co., Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses SK Biopharmaceuticals Co., Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features SK Biopharmaceuticals Co., Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate SK Biopharmaceuticals Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for SK Biopharmaceuticals Co., Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding SK Biopharmaceuticals Co., Ltd.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

SK Biopharmaceuticals Co., Ltd. Snapshot

SK Biopharmaceuticals Co., Ltd. Overview

Key Information

Key Facts

SK Biopharmaceuticals Co., Ltd. - Research and Development Overview

Key Therapeutic Areas

SK Biopharmaceuticals Co., Ltd. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

SK Biopharmaceuticals Co., Ltd. - Pipeline Products Glance

SK Biopharmaceuticals Co., Ltd. - Late Stage Pipeline Products

Phase III Products/Combination Treatment Modalities

SK Biopharmaceuticals Co., Ltd. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

SK Biopharmaceuticals Co., Ltd. - Early Stage Pipeline Products

IND/CTA Filed Products/Combination Treatment Modalities

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

SK Biopharmaceuticals Co., Ltd. - Drug Profiles

SKL-N05

Product Description

Mechanism of Action

R&D Progress

YKP-3089

Product Description

Mechanism of Action

R&D Progress

relenopride hydrochloride

Product Description

Mechanism of Action

R&D Progress

carisbamate

Product Description

Mechanism of Action

R&D Progress

SKL-15508

Product Description

Mechanism of Action

R&D Progress

SKL-A4R

Product Description

Mechanism of Action

R&D Progress

SKL-PD

Product Description

Mechanism of Action

R&D Progress

SKL-PSY

Product Description

Mechanism of Action

R&D Progress

N-2

Product Description

Mechanism of Action

R&D Progress

SKL-16036

Product Description

Mechanism of Action

R&D Progress

SKL-DEP

Product Description

Mechanism of Action

R&D Progress

SKL-G

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Multiple Sclerosis

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Neuropathic Pain

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Tauopathies and Alzheimer's Disease

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit TDP-43 for Amyotrophic Lateral Sclerosis

Product Description

Mechanism of Action

R&D Progress

SK Biopharmaceuticals Co., Ltd. - Pipeline Analysis

SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Target

SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Route of Administration

SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Molecule Type

SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action

SK Biopharmaceuticals Co., Ltd. - Recent Pipeline Updates

SK Biopharmaceuticals Co., Ltd. - Dormant Projects

SK Biopharmaceuticals Co., Ltd. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

carisbamate

SK Biopharmaceuticals Co., Ltd. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

SK Biopharmaceuticals Co., Ltd., Key Information

SK Biopharmaceuticals Co., Ltd., Key Facts

SK Biopharmaceuticals Co., Ltd. - Pipeline by Indication, 2016

SK Biopharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2016

SK Biopharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2016

SK Biopharmaceuticals Co., Ltd. - Phase III, 2016

SK Biopharmaceuticals Co., Ltd. - Phase II, 2016

SK Biopharmaceuticals Co., Ltd. - Phase I, 2016

SK Biopharmaceuticals Co., Ltd. - IND/CTA Filed, 2016

SK Biopharmaceuticals Co., Ltd. - Preclinical, 2016

SK Biopharmaceuticals Co., Ltd. - Discovery, 2016

SK Biopharmaceuticals Co., Ltd. - Pipeline by Target, 2016

SK Biopharmaceuticals Co., Ltd. - Pipeline by Route of Administration, 2016

SK Biopharmaceuticals Co., Ltd. - Pipeline by Molecule Type, 2016

SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action, 2016

SK Biopharmaceuticals Co., Ltd. - Recent Pipeline Updates, 2016

SK Biopharmaceuticals Co., Ltd. - Dormant Developmental Projects,2016

SK Biopharmaceuticals Co., Ltd. - Discontinued Pipeline Products, 2016

SK Biopharmaceuticals Co., Ltd., Other Locations

SK Biopharmaceuticals Co., Ltd., Subsidiaries

List of Figures

SK Biopharmaceuticals Co., Ltd. - Pipeline by Top 10 Indication, 2016

SK Biopharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2016

SK Biopharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2016

SK Biopharmaceuticals Co., Ltd. - Pipeline by Top 10 Target, 2016

SK Biopharmaceuticals Co., Ltd. - Pipeline by Route of Administration, 2016

SK Biopharmaceuticals Co., Ltd. - Pipeline by Molecule Type, 2016

SK Biopharmaceuticals Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll